Target intelligence / Profile preview

Bacterial and fungal cell components (Staphylococcus aureus and Candida albicans)

Molecular classification
Cell wall component, Cell membrane component, Enzyme, Polysaccharide
01

Overview

Bacterial and fungal cell components in Staphylococcus aureus and Candida albicans represent a diverse set of molecular targets involved in the structural integrity and virulence of these two major human pathogens (Todd & Peters, 2019, PubMed). In S. aureus, key components include peptidoglycan and teichoic acids, which are essential for cell wall stability and are targeted by glycopeptide and beta-lactam antibiotics (Lowry, 1998, NIH). C. albicans components include 1,3-beta-glucan, chitin, and ergosterol, which maintain fungal cell wall and membrane integrity and are targeted by echinocandins and azoles (Gow et al., 2017, Nature Reviews Microbiology). These organisms often coexist in polymicrobial biofilms, where their physical and chemical interactions lead to increased antimicrobial resistance and enhanced pathogenicity (StatPearls, 2023). Therapeutic strategies targeting these components must address the distinct biochemical pathways of both prokaryotic and eukaryotic cells while managing the complexities of co-infection (Nobile & Johnson, 2015, Annual Review of Microbiology).

Other names
Staphylococcus aureus and Candida albicans cell wall and membrane componentsPolymicrobial biofilm targetsS. aureus and C. albicans structural components
02

Mechanism of action

Inhibition of peptidoglycan synthesis, inhibition of 1,3-beta-glucan synthesis, disruption of cell membrane integrity, and inhibition of ergosterol biosynthesis.

03

Biological functions

Structural integrityBiofilm formationPathogenesisCellular adhesionOsmotic protection
04

Disease associations

InfectionSepsisBiofilm-associated infectionCandidiasisStaphylococcal infection
05

Safety considerations

Antimicrobial resistanceNephrotoxicityHepatotoxicityDisruption of the human microbiomeInfusion-related reactions
06

Interacting drugs

Vancomycin

6 more in the full profile.

07

Biomarkers

(1->3)-beta-D-glucanProcalcitoninC-reactive proteinMicrobial DNA (PCR)Galactomannan

Beyond the preview

Go deeper on Bacterial and fungal cell components (Staphylococcus aureus and Candida albicans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and fungal cell components (Staphylococcus aureus and Candida albicans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call